These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 415967)
21. Allograft cytotoxicity: differences between lytic and non-lytic interactions as revealed by ultrastructural histochemistry. Penfold PL; Jones B Immunology; 1979 Mar; 36(3):509-18. PubMed ID: 155654 [TBL] [Abstract][Full Text] [Related]
22. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity. Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852 [TBL] [Abstract][Full Text] [Related]
23. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells. Dennert G; Lennox ES J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868 [No Abstract] [Full Text] [Related]
24. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera. Newlands ES; Hay FC; Roitt IM Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324 [TBL] [Abstract][Full Text] [Related]
25. The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice. Lord EM; Nardella G Transplantation; 1980 Feb; 29(2):119-24. PubMed ID: 6766584 [TBL] [Abstract][Full Text] [Related]
26. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens. Bear HD Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451 [TBL] [Abstract][Full Text] [Related]
27. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
28. Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity. Bertoglio J; Gerlier D; Gerard JP Clin Exp Immunol; 1981 Apr; 44(1):137-44. PubMed ID: 6973429 [TBL] [Abstract][Full Text] [Related]
29. Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens. Engers HD; Thomas K; Cerottini JC; Brunner KT J Immunol; 1975 Aug; 115(2):356-60. PubMed ID: 807632 [TBL] [Abstract][Full Text] [Related]
30. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Liepins A; Nowicky JW Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312 [TBL] [Abstract][Full Text] [Related]
31. The nature of the K cell and the role of antibody-dependent cell mediated cytotoxicity (ADCC) in the rejection of tumours. Greenberg AH; Wolosin LB Ann Immunol (Paris); 1977; 128(1-2):485-91. PubMed ID: 848900 [TBL] [Abstract][Full Text] [Related]
32. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus. Mortensen RF; Ceglowski WS; Friedman H J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729 [No Abstract] [Full Text] [Related]
33. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2. Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360 [TBL] [Abstract][Full Text] [Related]
34. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure. Hiserodt JC J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707 [TBL] [Abstract][Full Text] [Related]
35. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
36. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect. Igarashi T; Okada M; Kishimoto S; Yamamura Y Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916 [TBL] [Abstract][Full Text] [Related]
37. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related]
38. GABA modulates cytotoxicity of immunocompetent cells expressing GABAA receptor subunits. Bergeret M; Khrestchatisky M; Tremblay E; Bernard A; Gregoire A; Chany C Biomed Pharmacother; 1998; 52(5):214-9. PubMed ID: 9755818 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of xenograft. II. Cytostatic effector mechanism for xenograft rejection. Nomoto K; Terasaka R; Himeno K; Shiraishi M Jpn J Exp Med; 1981 Apr; 51(2):81-7. PubMed ID: 6974263 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes. Waterfield JD; Nixon DF; Mair MG Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]